A detailed history of Ethic Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ethic Inc. holds 1,663 shares of RGEN stock, worth $240,236. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,663
Holding current value
$240,236
% of portfolio
0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $199,210 - $278,303
1,663 New
1,663 $247,000
Q1 2024

May 13, 2024

SELL
$170.78 - $208.42 $2,732 - $3,334
-16 Reduced 0.95%
1,663 $305,000
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $20,436 - $33,177
179 Added 11.93%
1,679 $301,000
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $98,117 - $124,792
-707 Reduced 32.03%
1,500 $238,000
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $78,068 - $101,694
-564 Reduced 20.35%
2,207 $312,000
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $5,090 - $6,537
33 Added 1.21%
2,771 $466,000
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $70,327 - $95,502
-433 Reduced 13.65%
2,738 $463,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $123,202 - $196,769
768 Added 31.96%
3,171 $593,000
Q2 2022

Aug 10, 2022

SELL
$140.68 - $188.02 $21,946 - $29,331
-156 Reduced 6.1%
2,403 $390,000
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $97,842 - $156,581
607 Added 31.1%
2,559 $481,000
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $17,826 - $21,921
72 Added 3.83%
1,952 $517,000
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $92,126 - $153,351
473 Added 33.62%
1,880 $543,000
Q2 2021

Aug 10, 2021

BUY
$165.87 - $220.95 $233,379 - $310,876
1,407 New
1,407 $281,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.